Cancer chemoprevention: A new way to treat cancer before it happens

K. Krishnan; M. T. Ruffin IV; D. E. Brenner

doi:10.1016/S0095-4543(05)70069-5

Cancer chemoprevention: A new way to treat cancer before it happens

K. Krishnan
, M. T. Ruffin IV
, D. E. Brenner

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

Cancer chemoprevention uses noncytotoxic drugs or nutrients to prevent, retard, or delay carcinogenesis. The future of cancer chemoprevention depends on understanding key cellular growth and proliferation-controlling events, developing markers of molecular carcinogenesis, surrogate endpoint biomarkers, and targeted chemopreventive approaches.

Original language	English (US)
Pages (from-to)	361-379
Number of pages	19
Journal	Primary Care - Clinics in Office Practice
Volume	25
Issue number	2
DOIs	https://doi.org/10.1016/S0095-4543(05)70069-5
State	Published - 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Pharmacology (medical)

Access to Document

10.1016/S0095-4543(05)70069-5

Cite this

@article{3524c230725e43ef9132681a5af504cc,

title = "Cancer chemoprevention: A new way to treat cancer before it happens",

abstract = "Cancer chemoprevention uses noncytotoxic drugs or nutrients to prevent, retard, or delay carcinogenesis. The future of cancer chemoprevention depends on understanding key cellular growth and proliferation-controlling events, developing markers of molecular carcinogenesis, surrogate endpoint biomarkers, and targeted chemopreventive approaches.",

author = "K. Krishnan and \{Ruffin IV\}, \{M. T.\} and Brenner, \{D. E.\}",

note = "Funding Information: The study was supported by Department of Veterans Affairs, VA Merit Review, American Cancer Society Grant EDT-55, National Cancer Institute CN-25429, and the University of Michigan Cancer Center Munn Fund. ",

year = "1998",

doi = "10.1016/S0095-4543(05)70069-5",

language = "English (US)",

volume = "25",

pages = "361--379",

journal = "Primary Care - Clinics in Office Practice",

issn = "0095-4543",

publisher = "W.B. Saunders",

number = "2",

}

TY - JOUR

T1 - Cancer chemoprevention

T2 - A new way to treat cancer before it happens

AU - Krishnan, K.

AU - Ruffin IV, M. T.

AU - Brenner, D. E.

N1 - Funding Information: The study was supported by Department of Veterans Affairs, VA Merit Review, American Cancer Society Grant EDT-55, National Cancer Institute CN-25429, and the University of Michigan Cancer Center Munn Fund.

PY - 1998

Y1 - 1998

N2 - Cancer chemoprevention uses noncytotoxic drugs or nutrients to prevent, retard, or delay carcinogenesis. The future of cancer chemoprevention depends on understanding key cellular growth and proliferation-controlling events, developing markers of molecular carcinogenesis, surrogate endpoint biomarkers, and targeted chemopreventive approaches.

AB - Cancer chemoprevention uses noncytotoxic drugs or nutrients to prevent, retard, or delay carcinogenesis. The future of cancer chemoprevention depends on understanding key cellular growth and proliferation-controlling events, developing markers of molecular carcinogenesis, surrogate endpoint biomarkers, and targeted chemopreventive approaches.

UR - https://www.scopus.com/pages/publications/0031832577

UR - https://www.scopus.com/pages/publications/0031832577#tab=citedBy

U2 - 10.1016/S0095-4543(05)70069-5

DO - 10.1016/S0095-4543(05)70069-5

M3 - Article

C2 - 9628956

AN - SCOPUS:0031832577

SN - 0095-4543

VL - 25

SP - 361

EP - 379

JO - Primary Care - Clinics in Office Practice

JF - Primary Care - Clinics in Office Practice

IS - 2

ER -

Cancer chemoprevention: A new way to treat cancer before it happens

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this